Expense

Worldwide Licensing Partnering Deals in Pharma, Biotech & Diagnostics, 2014-2020

Retrieved on: 
Tuesday, April 14, 2020
Patent law, Intellectual property law, Strategic alliances, Expense, Royalty payment, License

The Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020 report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies.

Key Points: 
  • The Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2020 report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies.
  • Key financial bnchmarks for headline, upfront, milestone and royalty rates
    There has been a long standing willingness for parties to enter licensing deals.
  • Licensing is a specific type of partnering deal whereby the parties to the deal agree to commercialize a compound, product or technology.
  • The chapter includes numerous case studies to enable understanding of both pure licensing deals and multicomponent deals where collaborative R&D forms a part.

Trucept Continues to Provide Industry-Leading Services via Work-at-Home Technologies

Retrieved on: 
Tuesday, April 14, 2020
Payroll, Employment compensation, Expense, Human resource management, Human activities

We realize the importance of these critical functions during these times, and it's the last thing our clients should be worried about."

Key Points: 
  • We realize the importance of these critical functions during these times, and it's the last thing our clients should be worried about."
  • Trucept remains committed to the safety of our employees and their families as we continue working to serve our client businesses throughout the United States."
  • True solutions, today and tomorrow: Trucept Inc. helps organizations focus on growing their business.
  • With a dedicated suite of tools and services designed exclusively for small to mid-size businesses, the company understands and provides services in the fields of payroll, human resources, employee benefits, compliance, and marketing & technology.

ImmuCell Receives $938,000 in Support under the Paycheck Protection Program

Retrieved on: 
Tuesday, April 14, 2020
Income statement, Employment compensation, Expense, Payroll

The funding helps the Company maintain operations and meet payroll during this unprecedented time of global economic challenge related to the COVID-19 pandemic.

Key Points: 
  • The funding helps the Company maintain operations and meet payroll during this unprecedented time of global economic challenge related to the COVID-19 pandemic.
  • At least 75% of such forgiven amounts must be used for eligible payroll costs.
  • Such forgiveness of indebtedness, in accordance with the CARES Act, does not give rise to taxable income to recipients like the Company.
  • In addition, there can be no assurance that future developments affecting us will be those that we anticipate.

DGAP-News: Ely Gold Royalties (TSXV: ELY) (OTCQB: ELYGF) Closes Additional Carlin Trend Royalty

Retrieved on: 
Tuesday, April 14, 2020
Expense, Intellectual property law, Patent law, Royalty payment, Ely, Ren

The leases in the REN Venture include the VEK/Andrus lease, 50% owned by VEK Associates, a company currently being acquired by Ely Gold.

Key Points: 
  • The leases in the REN Venture include the VEK/Andrus lease, 50% owned by VEK Associates, a company currently being acquired by Ely Gold.
  • The VEK/Andrus lease carries a 3.0% net smelter royalty on REN, therefore the closing of the REN NPI gives Ely Gold a second royalty interest at REN.
  • The REN NPI will give us a second royalty interest and, as with all Ely Gold royalty purchases, offers excellent leverage to gold prices."
  • About Ely Gold Royalties Inc.
    Ely Gold Royalties Inc. is a Vancouver-based, junior royalty company with development assets focused in Nevada and Quebec.

Congressional Candidate Josh Eisen Responds to Mark Cuban on Banks and the Payroll Protection Program

Retrieved on: 
Tuesday, April 14, 2020
Payroll, Employment compensation, Expense, Bank, Economy, Human activities

Josh Eisen, candidate forNew York's 17th Congressional District in Congress:

Key Points: 
  • Josh Eisen, candidate forNew York's 17th Congressional District in Congress:
    Mark Cuban recently complained that American banks are "playing games" by holding up loans under the Payroll Protection Program (PPP).
  • Cuban fails to consider companies that take the loans under PPP, but do not use the money for payroll or in ways which trigger forgiveness.
  • If not all workers, as many as possible with the information readily available from payroll reporting to the IRS.
  • That will relieve the banks, get cash to workers, and satisfy Mark Cuban and his spirits.

Mesabi Trust Press Release

Retrieved on: 
Monday, April 13, 2020
Banking, Professional services, Finance, Geology of Minnesota, Expense, Intellectual property law, Patent law, Royalty payment, Mesabi Range, Trust law, Law, Academic disciplines, Legal systems

The Trustees of Mesabi Trust (NYSE:MSB) declared a distribution of fifty-six cents ($0.56) per Unit of Beneficial Interest payable on May 20, 2020 to Mesabi Trust Unitholders of record at the close of business on April 30, 2020.

Key Points: 
  • The Trustees of Mesabi Trust (NYSE:MSB) declared a distribution of fifty-six cents ($0.56) per Unit of Beneficial Interest payable on May 20, 2020 to Mesabi Trust Unitholders of record at the close of business on April 30, 2020.
  • Quarterly royalty payments from Northshore for iron ore shipments during the first calendar quarter, which are payable to Mesabi Trust under the royalty agreement, are due on April 30, 2020, together with the quarterly royalty report.
  • After receiving the quarterly royalty report, Mesabi Trust plans to file a summary of the quarterly royalty report with the Securities and Exchange Commission in a Current Report on Form 8-K.
  • Further, substantial portions of royalties earned by Mesabi Trust are based on estimated prices that are subject to quarterly and final adjustments, which can be positive or negative, and are dependent in part on multiple price and inflation index factors under agreements to which Mesabi Trust is not a party and that are not known until after the end of a contract year.

PrismHR and Payroll Funding Join to Provide Quick Access to Funding for HR Service Provider's Small Business Clients

Retrieved on: 
Monday, April 13, 2020
Employment compensation, Expense, Payroll

Payroll Funding exclusively provides funding to HR service providers' clients without a written application process, and once approved, no collateral or personal guarantee or security is required.

Key Points: 
  • Payroll Funding exclusively provides funding to HR service providers' clients without a written application process, and once approved, no collateral or personal guarantee or security is required.
  • "We are excited to work with PrismHR to enable HR service providers to offer Payroll Funding to their clients directly through PrismHR' s Marketplace.
  • During these stressful economic times, HR service providers that rely on PrismHR are looking for every available revenue for short-term funding.
  • Through PrismHR' s platform, access to Payroll Funding is a click away," said Will Robins, President of Payroll Funding.

Royalty Rates in Worldwide Pharma & Biotech Dealmaking 2010-2020: Case Studies, Trends, Leading Deals and More

Retrieved on: 
Thursday, April 9, 2020
Expense, Intellectual property law, Patent law, Royalty payment

The initial chapters of this report provide an orientation of royalty rate trends in pharma and biotech since 2010.

Key Points: 
  • The initial chapters of this report provide an orientation of royalty rate trends in pharma and biotech since 2010.
  • Chapter 5 provides an insight into companies active in disclosing royalty rates as well as those deals attracting the highest royalty rates, and why.
  • The report also includes numerous table and figures that illustrate the trends in royalty rates in pharma and biotech deal making since 2010.
  • In conclusion, this report provides everything a prospective dealmaker needs to know about royalty rates in the pharma and biotech sector.

Royalty Rate Trends in Pharma & Biotech Dealmaking 2010-2020 - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 9, 2020
Pharmaceutical, Other Professional Services, Professional services, Health, Expense, Intellectual property law, Patent law, Royalty payment

The "Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2020" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Royalty Rate Trends in Pharma and Biotech Dealmaking 2010-2020" report has been added to ResearchAndMarkets.com's offering.
  • The initial chapters of this report provide an orientation of royalty rate trends in pharma and biotech since 2010.
  • The report also includes numerous table and figures that illustrate the trends in royalty rates in pharma and biotech deal making since 2010.
  • In conclusion, this report provides everything a prospective dealmaker needs to know about royalty rates in the pharma and biotech sector.

Rise People Offers Free HR and Payroll to Canadian Businesses in Response to the COVID-19 Crisis

Retrieved on: 
Thursday, April 9, 2020
Employment, Work, Employee relations, Payroll, Employment compensation, Expense, Telecommuting, Human resource management system

Businesses can sign up for Rises bundled HR and payroll solutions free of charge until the pandemic subsides.

Key Points: 
  • Businesses can sign up for Rises bundled HR and payroll solutions free of charge until the pandemic subsides.
  • The platform provides access to the Rise mobile app that enables employees and managers to stay connected and manage time-off requests.
  • Rise will also be offering new tools to help employers track and process job applications and onboard new employees while working remotely.
  • Rise offers a modern suite of HR, benefits, and payroll solutions that is used by thousands of employers across Canada.